Alan Skarbnik (@askarbnik) 's Twitter Profile
Alan Skarbnik

@askarbnik

Oncologist.Rock Musician. Grill Master. Awesome Dad. Proud Brazilian Jew. Director, Lymphoma and CLL Program and IEC Program @novanthealth

ID: 999010996034338818

linkhttp://linkedin.com/in/alan-skarbnik-56a921173 calendar_today22-05-2018 19:35:57

2,2K Tweet

2,2K Followers

1,1K Following

Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

#Hematology Impressive results of #epcoritamab + GEMOX in transplant ineligible R/R DLBCL patients with ORR/CR 85%/61% and even better if given in 2L with ORR/CR 90/74% #lymsm

#Hematology Impressive results of #epcoritamab + GEMOX in transplant ineligible R/R DLBCL patients with ORR/CR 85%/61% and even better if given in 2L with ORR/CR 90/74% #lymsm
Alan Skarbnik (@askarbnik) 's Twitter Profile Photo

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

Nashville Hematology Conference (@nashvilleheme) 's Twitter Profile Photo

Get ready for #NashvilleHeme25! Join us for "Treating Later Relapse: 3L and Beyond", moderated by Dr. Jason Chandler with Drs. Alan Skarbnik, Mazyar Shadman, MD MPH, and Susan Bal. Plus, an exciting debate moderated by Dr. Rahul Banerjee, MD, FACP, featuring Drs. Sham Mailankody and Ajai Chari on CAR-T

Get ready for #NashvilleHeme25! Join us for "Treating Later Relapse: 3L and Beyond", moderated by Dr. Jason Chandler with Drs. <a href="/ASkarbnik/">Alan Skarbnik</a>, <a href="/mshadman/">Mazyar Shadman, MD MPH</a>, and <a href="/SusanBal9/">Susan Bal</a>. Plus, an exciting debate moderated by Dr. <a href="/RahulBanerjeeMD/">Rahul Banerjee, MD, FACP</a>, featuring Drs. Sham Mailankody and <a href="/AjaiChari/">Ajai Chari</a> on CAR-T
Adam Kittai (@adamkittai) 's Twitter Profile Photo

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL | Blood Cancer Journal rdcu.be/eaHne

Nashville Hematology Conference (@nashvilleheme) 's Twitter Profile Photo

Save the date! #NashvilleHeme26 returns February 26-28, 2026 to the iconic Country Music Hall of Fame® and Museum in Nashville. Don’t miss another anticipated CE conference with expert insights, engaging discussions, and valuable connections! Follow us to stay connected!

Save the date! #NashvilleHeme26 returns February 26-28, 2026 to the iconic Country Music Hall of Fame® and Museum in Nashville. Don’t miss another anticipated CE conference with expert insights, engaging discussions, and valuable connections! Follow us to stay connected!
OncLive.com (@onclive) 's Twitter Profile Photo

Hear Alan Skarbnik of Novant Health review interim Phase 3 AMPLIFY data on fixed-duration acalabrutinib plus venetoclax ± obinutuzumab vs. chemoimmunotherapy in treatment-naive CLL. Watch here: onclive.com/view/fixed-dur…